Millendo Therapeutics
Ann Arbor
About Millendo Therapeutics
Millendo Therapeutics is a biopharmaceutical company previously primarily focused on developing novel treatments for endocrine diseases where current therapies do not exist or are insufficient. Millendo seeks to create distinct and transformative treatments where there is a significant unmet medical need.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $191.5M
- Funding stage: M&A
- Last round: Post-IPO Equity (Mar 2020)
- Ticker: nasdaq:MLND
- Website: millendo.com
- Phone: 7348459000
Industries & Categories
Biotechnology, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/millendo-therapeutics-182085 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.